Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV I Infection”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05471076
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)WithdrawnNCT05539989
What this trial is testing

Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Who this might be right for
TuberculosisHIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Testing effectiveness (Phase 2)Study completedNCT00513526
What this trial is testing

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Who this might be right for
InfectionPrecancerous Condition
AIDS Malignancy Consortium 112
Early research (Phase 1)Study completedNCT03231943
What this trial is testing

GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 78
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Post-approval studies (Phase 4)UnknownNCT03774108
What this trial is testing

Metformin and Systemic Inflammation in HIV

Who this might be right for
PreDiabetesHIV-1-infection
Hospital Civil de Guadalajara 40
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527418
What this trial is testing

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Who this might be right for
Recent HIV-1 Infection
Eva Bonfill 24
Testing effectiveness (Phase 2)WithdrawnNCT03549689
What this trial is testing

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)

Who this might be right for
HIV/AIDSHIV-1-infectionOsteopenia
Philip Grant
Not applicableStudy completedNCT02592174
What this trial is testing

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 220
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Study completedNCT00002006
What this trial is testing

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Not applicableEnded earlyNCT00341887
What this trial is testing

Epidemiological Study of HIV in the South African National Defense Force

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 8,676
Testing effectiveness (Phase 2)Study completedNCT00189904
What this trial is testing

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 151
Large-scale testing (Phase 3)Active Not RecruitingNCT04776252
What this trial is testing

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 2,000
Early research (Phase 1)Study completedNCT00001647
What this trial is testing

White Blood Cell Infusions to Treat HIV Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation